mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
0.039 |
0.8 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.8 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.8 |
mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
0.037 |
0.8 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
CEP-701 |
FIMM |
pan-cancer |
AAC |
0.03 |
0.8 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |